Events & Conferences

In this section, explore the key scientific events and conferences where Clinisciences takes center stage—whether as a sponsor or an active participant. From high-impact international congresses to focused expert symposia, our presence reflects our dedication to advancing research and connecting with the scientific community. These events are more than just dates on a calendar—they're opportunities to exchange ideas, showcase innovative tools, and stay at the forefront of scientific discovery. Join us where breakthroughs happen!

BtBsDay 2026

BtBsDay 2026

CliniSciences is pleased to announce its participation as an official sponsor of BtBsDay 2026, the annual scientific meeting of the Department of Biotechnology and Biosciences at the University of Milano-Bicocca. This one-day event highlights the department’s research activities and provides a dedicated forum for scientific exchange through oral presentations, poster sessions, and an invited keynote lecture, covering a broad range of topics in biotechnology and biosciences. Where: University of Milano-Bicocca, Sironi Room (U4-08), Milan, Italy When: 17 February 2026

Conference & School on Extracellular Vesicles and Nanoparticles

Conference & School on Extracellular Vesicles and Nanoparticles

CSEVP-2026, the Conference & School on Extracellular Vesicles and Nanoparticles, will take place in Frascati and Rome, Italy, from 16–20 February 2026, bringing together experts and early-career researchers to explore advances in EV and nanoparticle biology.

SIGNET 2026

SIGNET 2026

SIGNET 2026 brings together immunologists on 11 March 2026 in Perth for a one-day symposium featuring keynote talks, poster sessions, and networking to support collaboration in immunology.

STEMNet 2026

STEMNet 2026

STEMNet 2026, held in Bologna on 12–13 March 2026, will showcase advances in stem cell research and translational cell therapy through scientific sessions, posters, and young investigator awards.

SY-Stem

SY-Stem

CliniSciences is proud to participate as an official sponsor of SY-Stem 2026, an international symposium dedicated to fostering the next generation of stem cell researchers. This annual scientific meeting brings together early-career scientists, emerging group leaders, and established experts to discuss the latest advances in stem cell biology in an interactive and collaborative setting

1st SIB Young Meeting

1st SIB Young Meeting

De 25 a 27 de março de 2026, o 1º SIB Young Meeting será realizado em Abano Terme (Pd), Itália, oferecendo a jovens bioquímicos e biocientistas moleculares um fórum dedicado ao networking, formação e discussão de temas de investigação emergentes.

Da bancada à liderança - Um workshop para jovens investigadores em biologia

Da bancada à liderança - Um workshop para jovens investigadores em biologia

O 2.º Workshop para Jovens Investigadores da GBM, intitulado «Da bancada à liderança», será realizado de 13 a 16 de abril de 2026 na Universidade de Regensburg, na Alemanha, e é dedicado à formação em liderança e gestão para investigadores em início de carreira nas ciências da vida.

39ᵉ Congrès AFH

39ᵉ Congrès AFH

The 39ᵉ Congrès AFH 2026 will take place in Nîmes, France, from 10–12 June 2026, bringing together histology and histotechnology professionals to explore the latest scientific advances, techniques, and laboratory innovations.

Press Release: Genexpath joins CliniSciences Group

Press Release: Genexpath joins CliniSciences Group

A CliniSciences reforça a sua liderança em biologia molecular e hemato-oncologia com a aquisição estratégica da Genexpath, especialista em soluções de diagnóstico in vitro para linfomas e sarcomas.

A REDINN visita a empresa parceira da NEOSETAC em Barcelona

A REDINN visita a empresa parceira da NEOSETAC em Barcelona

A REDINN visita a empresa parceira da NEOSETAC em Barcelona

Comunicado de imprensa: Oncomedics junta-se ao Grupo CliniSciences

Comunicado de imprensa: Oncomedics junta-se ao Grupo CliniSciences

O CliniSciences Group, distribuidor europeu de reagentes e equipamentos para a investigação científica e o diagnóstico médico, adquiriu a Oncomedics, uma empresa francesa de biotecnologia especializada na personalização de tratamentos contra o cancro.